Neurofibromatosis (NF-1), know as Von Recklinghausen's disease, is one of the most common genetic disorders, affecting about 1 in 3,500 people. Inherited in an autosomal dominant fashion, this disorder results in lesions of the nervous, visual and integumentary system that are highly variable in their level of severity. NF-1 is caused by a mutation of a gene located on chromosome 17 which encodes the protein neurofibromin, a negative regulator of cell signaling pathways for the control of cellular division. Thusly, the NF gene is referred to as a tumor suppressing gene and mutations result in mostly benign tumorous growths and more rarely malignancies. NF-1 phenotypically presents itself with a variety of characteristic manifestations. Wh...
Abstract Background The aim of this retrospective study was to define clinical and molecular charact...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...
Neurofibromatosis type 1 (NF1) or von Recklinghausen disease is one of the most common genetic disea...
Neurofibromatosis-1 (NF1) is one of the most common hereditary multisystemic disorders. The disease ...
Neurofibromatosis type 1 (NF1) or Von Recklinghausen's disease is a dominantly inherited genetic, mu...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
Neurofibromatosis type 1 (NF1) is a rare genetic disorder, characterized by the development of benig...
Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recogni...
Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recogni...
BACKGROUND: Neurofibroma occurs as isolated or multiple lesions frequently associated with neurofibr...
BACKGROUND: Neurofibroma occurs as isolated or multiple lesions frequently associated with neurofibr...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...
Neurofibromatosis type 1 (NF1) is a neurocutaneous condition with an autosomal dominant pattern of i...
Von Recklinghausen neurofibromatosis (NF1) is a common autosomal dominant disorder of humans. Linkag...
Abstract Background The aim of this retrospective study was to define clinical and molecular charact...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...
Neurofibromatosis type 1 (NF1) or von Recklinghausen disease is one of the most common genetic disea...
Neurofibromatosis-1 (NF1) is one of the most common hereditary multisystemic disorders. The disease ...
Neurofibromatosis type 1 (NF1) or Von Recklinghausen's disease is a dominantly inherited genetic, mu...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
Neurofibromatosis type 1 (NF1) is a rare genetic disorder, characterized by the development of benig...
Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recogni...
Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recogni...
BACKGROUND: Neurofibroma occurs as isolated or multiple lesions frequently associated with neurofibr...
BACKGROUND: Neurofibroma occurs as isolated or multiple lesions frequently associated with neurofibr...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...
Neurofibromatosis type 1 (NF1) is a neurocutaneous condition with an autosomal dominant pattern of i...
Von Recklinghausen neurofibromatosis (NF1) is a common autosomal dominant disorder of humans. Linkag...
Abstract Background The aim of this retrospective study was to define clinical and molecular charact...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...
Background: The aim of this retrospective study was to define clinical and molecular characteristics...